Yui Yamamoto

2.2k total citations
56 papers, 1.7k citations indexed

About

Yui Yamamoto is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Yui Yamamoto has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 8 papers in Neurology. Recurrent topics in Yui Yamamoto's work include Peroxisome Proliferator-Activated Receptors (18 papers), Receptor Mechanisms and Signaling (9 papers) and Neuropeptides and Animal Physiology (8 papers). Yui Yamamoto is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (18 papers), Receptor Mechanisms and Signaling (9 papers) and Neuropeptides and Animal Physiology (8 papers). Yui Yamamoto collaborates with scholars based in Japan, United States and China. Yui Yamamoto's co-authors include Kohji Fukunaga, Yuji Owada, Norifumi Shioda, Shigeki Moriguchi, Yoshiteru Kagawa, Hirofumi Miyazaki, Yuki Yasumoto, Feng Han, Ariful Islam and Miki Nakajima and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Diabetes Care.

In The Last Decade

Yui Yamamoto

55 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yui Yamamoto Japan 24 860 404 261 236 220 56 1.7k
Hyung Hwan Baik South Korea 28 724 0.8× 298 0.7× 439 1.7× 402 1.7× 146 0.7× 49 2.0k
Marina G. Sergeeva Russia 24 710 0.8× 246 0.6× 259 1.0× 341 1.4× 145 0.7× 72 1.7k
Antonietta Bernardo Italy 28 1.1k 1.3× 357 0.9× 677 2.6× 519 2.2× 207 0.9× 50 2.2k
Helena Cimarosti Brazil 26 844 1.0× 439 1.1× 247 0.9× 244 1.0× 100 0.5× 54 1.7k
Janneth González Colombia 26 882 1.0× 421 1.0× 478 1.8× 458 1.9× 106 0.5× 75 2.2k
Anamitra Ghosh United States 21 1.1k 1.3× 673 1.7× 539 2.1× 492 2.1× 162 0.7× 33 2.4k
Aiguo Xuan China 21 773 0.9× 331 0.8× 321 1.2× 549 2.3× 130 0.6× 39 1.8k
Zhixing Yao United States 18 996 1.2× 280 0.7× 177 0.7× 499 2.1× 121 0.6× 30 2.1k
Woosuk Kim South Korea 25 601 0.7× 340 0.8× 296 1.1× 336 1.4× 88 0.4× 108 1.7k
Yasuko Kitagishi Japan 23 1.0k 1.2× 188 0.5× 114 0.4× 299 1.3× 241 1.1× 55 1.9k

Countries citing papers authored by Yui Yamamoto

Since Specialization
Citations

This map shows the geographic impact of Yui Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yui Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yui Yamamoto more than expected).

Fields of papers citing papers by Yui Yamamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yui Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yui Yamamoto. The network helps show where Yui Yamamoto may publish in the future.

Co-authorship network of co-authors of Yui Yamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yui Yamamoto. A scholar is included among the top collaborators of Yui Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yui Yamamoto. Yui Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyazaki, Hirofumi, Shuhan Yang, Dandan Yang, et al.. (2025). FABP7 in Hepatic Macrophages Promotes Fibroblast Activation and CD4 + T‐Cell Migration by Regulating M2 Polarization During Liver Fibrosis. Journal of Immunology Research. 2025(1). 6987981–6987981. 2 indexed citations
2.
Umaru, Banlanjo Abdulaziz, Yui Yamamoto, Hiroki Shima, et al.. (2024). Polyunsaturated fatty acids-induced ferroptosis suppresses pancreatic cancer growth. Scientific Reports. 14(1). 4409–4409. 20 indexed citations
3.
Umaru, Banlanjo Abdulaziz, Yoshiteru Kagawa, Yuki Ohsaki, et al.. (2022). Oleic acid‐bound FABP7 drives glioma cell proliferation through regulation of nuclear lipid droplet formation. FEBS Journal. 290(7). 1798–1821. 15 indexed citations
4.
Yamamoto, Yui, et al.. (2021). Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency. Diabetologia. 65(1). 234–245. 15 indexed citations
5.
Yamamoto, Yui & Yuji Owada. (2021). Possible involvement of fatty acid binding proteins in psychiatric disorders. Anatomical Science International. 96(3). 333–342. 11 indexed citations
6.
Sato, Sho, Subrata Kumar Shil, Banlanjo Abdulaziz Umaru, et al.. (2019). The role of fatty acid binding protein 7 in spinal cord astrocytes in a mouse model of experimental autoimmune encephalomyelitis. Neuroscience. 409. 120–129. 23 indexed citations
7.
Islam, Ariful, Yui Yamamoto, Majid Ebrahimi, et al.. (2016). Omega-3 fatty acids transport through the placenta. Asian Journal of Medical and Biological Research. 2(1). 1–8. 2 indexed citations
9.
Kida, Hiroyuki, et al.. (2016). Motor Training Promotes Both Synaptic and Intrinsic Plasticity of Layer II/III Pyramidal Neurons in the Primary Motor Cortex. Cerebral Cortex. 26(8). 3494–3507. 60 indexed citations
10.
Miyazaki, Hirofumi, Tomoo Sawada, Zhiqian Yu, et al.. (2014). Fatty Acid Binding Protein 7 Regulates Phagocytosis and Cytokine Production in Kupffer Cells during Liver Injury. American Journal Of Pathology. 184(9). 2505–2515. 13 indexed citations
11.
Marzook, N. Bishara, et al.. (2014). Methodology for the Efficient Generation of Fluorescently Tagged Vaccinia Virus Proteins. Journal of Visualized Experiments. e51151–e51151. 8 indexed citations
15.
Yamamoto, Yui, Norifumi Shioda, Feng Han, Shigeki Moriguchi, & Kohji Fukunaga. (2013). The Novel Cognitive Enhancer ST101 Enhances Acetylcholine Release in Mouse Dorsal Hippocampus Through T-type Voltage-Gated Calcium Channel Stimulation. Journal of Pharmacological Sciences. 121(3). 212–226. 29 indexed citations
16.
Moriguchi, Shigeki, Norifumi Shioda, Yui Yamamoto, Hideaki Tagashira, & Kohji Fukunaga. (2012). The T‐type voltage‐gated calcium channel as a molecular target of the novel cognitive enhancer ST101: enhancement of long‐term potentiation and CaMKII autophosphorylation in rat cortical slices. Journal of Neurochemistry. 121(1). 44–53. 50 indexed citations
18.
Shioda, Norifumi, Yui Yamamoto, Feng Han, Shigeki Moriguchi, & Kohji Fukunaga. (2011). Neurochemical Mechanisms of a Novel Alzheimer's Disease Therapeutics on Improvement of Cognition and Depressive Behavior. YAKUGAKU ZASSHI. 131(4). 505–511. 4 indexed citations
19.
Han, Feng, Tetsuo Nakano, Yui Yamamoto, et al.. (2009). Improvement of depressive behaviors by nefiracetam is associated with activation of CaM kinases in olfactory bulbectomized mice. Brain Research. 1265. 205–214. 22 indexed citations
20.
Yamamoto, Yui, Norifumi Shioda, Feng Han, et al.. (2009). Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation. Brain Research. 1295. 218–229. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026